Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal

Human and Experimental Toxicology

Volumn 16, Issue 8, 1997, Pages 449-459

  Scherer, G ^a   Richter, E ^b  

^a Analytisch biologisches F   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Benzene; Biomonitoring; Carbon monoxide; Cotinine; Environmental tobacco smoke; Thiocyanate

Indexed keywords

AROMATIC AMINE; BENZENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; COTININE; HYDROXYPROLINE; MUTAGENIC AGENT; NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON; SULFIDE; THIOCYANATE; TOBACCO SMOKE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; BODY FLUID; CARDIOVASCULAR RISK; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; ENZYME INDUCTION; ERYTHROCYTE; EXPIRED AIR; HUMAN; HYDROXYPROLINE URINE LEVEL; MUTAGENIC ACTIVITY; PASSIVE SMOKING; PLACENTA; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING; URINE LEVEL;

NICOTIANA TABACUM;

EID: 0030830056     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600806     Document Type: Article

References (119)

1. Environmental Protection Agency. Respiratory Health Effects of Passive Smoking: Lung Cancer and other disorders. Washington, EPA /600/6-90/ 006F, 1992.
2. Jarvis MJ. Application of biochemical intake markers to passive smoking measurement and risk estimation. Mutat Res 1989; 222: 101-110.
3. Coburn RF. Endogenous carbon monoxide production. New Engl J Med 1970; 282: 207-209.
4. Guerin MR, Jenkins RA, Tomkins BA. The Chemistry of Environmental Tobacco Smoke: Composition and Measurement. Boca Raton, Ann Arbor, London, Tokyo, Lewis Publishers, 1992.
5. Borgers D, Junge B. Thiocyanate as an indicator of tobacco smoking. Prev Med 1979; 8: 351-357.
6. Klus H, Kuhn H. Verteilung verschiedener Tabakrauchbestandteile auf Haupt- und Nebenstromrauch (Eine Übersicht). Beitr Tabakforsch Int 1982; 11: 229-265.
7. Baker RR, Proctor CJ. The origins and properties of environmental tobacco smoke. Environ Int 1990; 16; 231-245.
8. Phillips K, Howard DA, Browne D, Lewsley JM. Assessment of personal exposures to environmental tobacco smoke in British nonsmokers. Environ Int 1994; 20: 693-712.
9. Scherer G et al. Contribution of tobacco smoke to environmental benzene exposure in Germany. Environ Int 1995; 21: 779-789.
10. Domino E-F, Hornbach E, Demana T. Relevance of nicotine content of common vegetables to the identification of passive tobacco smokers. Med Sci Res 1993; 21: 571-572.
11. Scherer G et al. Pharmacokinetics of nicotine, cotinine, and 3′-hydroxycotinine in cigarette smokers. Klin Wochenschr 1988; 66, Suppl: 5-11.
12. Pirkle JL et al. Exposure of the US population to environmental tobacco smoke. JAMA 1996; 275: 1233-1240.
13. Reasor MJ, Will JA. Assessing exposure to environmental tobacco smoke: is it valid to extrapolate from active smoking? J Smoking-Related Dis 1991; 2: 111-127.
14. Scherer G et al. Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers. Int Arch Occup Environ Health 1990; 62: 459-466.
15. Haley NJ, Sepkovic DW, Hoffmann D. Elimination of cotinine from body fluids: Disposition in smokers and nonsmokers. Am J Publ Health 1989; 79: 1046-1048.
16. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18: 188-204.
17. Neurath GB et al. Gas-particulate phase distribution and decay rates of constituents in ageing environmental tobacco smoke. Environ Technol 1991; 12: 581-590.
18. Ogden MW. Occupational exposure to environmental tobacco smoke. JAMA 1996; 14: 441.
19. Fishbein L. Benzene. Uses, occurrences and exposure, In Fishbein L, O'Neill IK (eds): IARC Scientific Publications No. 85: Environmental Carcinogens Methods of Analysis and Exposure Measurement. Volume 10 - Benzene and Alkylated Benzenes. Lyon, International Agency for Research on Cancer, 1988: pp. 67-96.
20. Müller J. Innen- und Außenluftmessungen an einer innerstädtischen Hauptverkehrsstraße. Staub-Reinhalt Luft 1991; 51: 147-154.
21. Chriske HW, Brockhaus A, Ewers U. Benzolbelastung von im Außen- und Innendienst tätigen Personen einer verkehrsreichen Großstadt. Arbeitsmed Sozialmed Präventivmed 1991; 26: 483-485.
22. Brunnemann KD, Kagan MR, Cox JE, Hoffmann D. Analysis of 1,3-butadiene and other selected gasphase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 1990; 11: 1863-1868.
23. Krause C et al. Occurrence of volatile organic compounds in the air of 500 homes in the Federal Republic of Germany, In Seifert B, Esdorn H, Fischer M, Rüden H, Wegner J (eds): Indoor Air '87. Proceedings of the 4th International Conference on Indoor Air Quality and Climate. Volatile Organic Compounds, Combustion Gases, Particles and Fibres, Microbiological Agents. Berlin, Institute for Water, Soil and Air Hygiene, 1987: vol 1, pp. 102-111.
24. Wallace LA. Major sources of benzene exposure. Environ Health Perspect 1989; 82: 165-169.
25. Lauwerys R, Buchet JP. Biological monitoring of exposure to benzene, toluene and xylene, In Fishbein L, O'Neill IK (eds): Environmental Carcinogens Methods of Analysis and Exposure Measurement. Volume 10 - Benzene and Alkylated Benzenes. Lyon, International Agency for Research on Cancer, 1988: pp. 205-222.
26. Angerer J, Scherer G, Schaller KH, Müller J. The determination of benzene in human blood as an indicator of environmental exposure to volatile aromatic compounds. Fresenius J Anal Chem 1991; 339: 740-742.
27. Riedel K et al. Determination of benzene and alkylated benzenes in ambient and exhaled air by microwave desorption coupled with gas chromatography-mass spectrometry. J Chromatogr 1996; 719: 383-389.
28. Inoue O et al. Urinary t,t-muconic acid as an indicator of exposure to benzene. Br J Ind Med 1989; 46: 122-127.
29. Strommel P et al. Determination of S-phenylmercapturic acid in the urine - an improvement in the biological monitoring of benzene exposure. Carcinogenesis 1989; 10: 279-282.
30. Ducos P et al. trans, trans-Muconic acid, a reliable biological indicator for the detection of individual benzene exposure down to the ppm level. Int Arch Occup Environ Health 1992; 64: 309-313.
31. Heavner DL, Morgan WT, Ogden MW. Determination of volatile organic compounds and ETS apportionment in 49 homes. Environ Int 1995; 21: 3-21.
32. Hattemer-Frey HA, Travis CC. Benzo-a-pyrene: Environmental partitioning and human exposure. Toxicol Ind Health 1991; 7: 141-157.
33. World Health Organization. Guidelines for drinking-water quality. Vol. 1 Recommendations. Geneva, World Health Organization, 1984.
34. Grimmer G, Naujack KW, Dettbarn G. Gaschromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes. Toxicol Lett 1987; 35: 117-124.
35. Chuang JC, Mack GA, Kuhlman MR, Wilson NK. Polycyclic aromatic hydrocarbons and their derivatives in indoor and outdoor air in an eight-home study. Atmospheric Environment 1991; 25: 369-380.
36. Martin F et al. Urinary excretion of hydroxy-phenanthrenes after intake of polycyclic aromatic hydrocarbons. Environ Int 1989; 15: 41-47.
37. Perera FP et al. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst 1987; 79: 449-456.
38. Crawford FG et al. Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst 1994; 86: 1398-1402.
39. Autrup H, Beck Vestergaard A, Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 1995; 16: 1305-1309.
40. Pastorelli R et al. Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust. Carcinogenesis 1996; 17: 2389-2394.
41. Tas S, Buchet JP, Lauwerys R. Determinants of benzo[a]pyrene diol epoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons. Int Arch Occup Environ Health 1994; 66: 343-348.
42. International Agency for Research on Cancer. Tobacco Smoking. IARC Monographs on the evolution of the carcinogenic risk of chemicals to humans. Lyon, IARC, 1986: vol 38.
43. Grimmer G, Schneider D. Intercept-reactant method for the determination of aromatic amines in mainstream tobacco smoke. Beitr Tabakforsch Int 1995; 16: 141-156.
44. Hammond SK et al. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993; 85: 474-478.
45. Tokiwa H, Nakagawa R, Horikawa K. Mutagenic/ carcinogenic agents in indoor air pollutants: The dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. Mutat Res 1985; 157: 39-47.
46. Richter E et al. Comparison of biomarkers for exposure to environmental tobacco smoke: Cotinine and haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and nonsmoking women, in Maroni M (ed): healthy buildings '95 an international conference on healthy buildings in mild climate. Milano, healthy buildings '95, 1995: pp. 599-604.
47. Falter B, Kutzer C, Richter E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin Investig 1994; 72: 364-371.
48. Richter E. Gesundheitsgefährdung durch Passivrauchen. Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie (DGPT) Mitteilungen 1996; 19: 65-66.
49. Hoffmann D, Rivenson A, Hecht SS. The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung. Crit Rev Toxicol 1996; 26: 199-211.
50. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific JV-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 1994; 41: 1-52.
51. Brunnemann KD, Cox JE, Hoffmann D. Analysis of tobacco-specific N-nitrosamines in indoor air. Carcinogenesis 1992; 13: 2415-2418.
52. Klus H et al. Tobacco-specific and volatile N-nitrosamines in environmental tobacco smoke of offices. Indoor Environment 1992; 1: 348-350.
53. Tricker AR et al. Tobacco-specific and volatile nitrosamines in indoor air of smoker and nonsmoker homes, in Weber L (ed): Indoor Air Pollution. Proceedings of the International Conference held at the University of Ulm, Ulm, Germany, 5-7 October 1994. Rothenfluh, Switzerland, Indoor Air International, 1994: pp. 310-316.
54. Hecht SS. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 1996; 26: 163-181.
55. Hecht SS et al. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New Engl J Med 1993; 329: 1543-1546.
56. Meger M et al. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers. European Journal of Cancer Prevention 1996; 5 (Supp. l): 121-124.
57. Hecht SS et al. Tobacco-specific nitrosamine adducts: Studies in laboratory animals and humans. Environ Health Perspect 1993; 99: 57-63.
58. Richter E, Tricker AR. Nicotine inhibits the metabolic activation of the tobacco- specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis 1994; 15: 1061-1064.
59. Tricker AR et al. Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites. Carcinogenesis 1993; 14: 1409-1414.
60. Hoffmann D, Brunnemann K. Endogenous formation of N-nitrosoproline in cigarette smokers. Cancer Res 1983; 43: 5570-5574.
61. Hoffmann D, Haley NJ, Adams JD, Brunnemann KD. Tobacco sidestream smoke; Uptake by nonsmokers. Prev Med 1984; 13: 608-617.
62. Scherer G, Adlkofer F. Endogenous formation of N-nitrosoproline in smokers and nonsmokers. Banbury Report 1986; 23: 137-148.
63. Randerath E, Mittal D, Randerath K. Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': preference for lung and heart DNA. Carcinogenesis 1988; 9: 75-80.
64. 32P-postlabelling analysis of DNA adducts in monocytes of smokers and passive smokers. Int Arch Occup Environ Health 1990; 62: 299-303.
65. Scherer G, Conze C, Tricker AR, Adlkofer F. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS), Clin Investig 1992; 70: 352-367.
66. Everson RB et al. Detection of smoking-related covalent DNA adducts in human placenta. Science 1986; 231: 54-57.
67. Binkova B et al. DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. Carcinogenesis 1995; 16: 1037-1046.
68. Daube H et al. DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status. J Cancer Res Clin Oncol 1997; 123: 141-151.
69. Stehlik G, Richter O, Altmann H. Concentration of dimethylnitrosamine in the air of smoke-filled rooms. Ecotoxicol Environ Safety 1982; 6: 495-500.
70. Tricker AR, Ditrich C, Preussmann R. N-Nitroso compounds in cigarette tobacco and their occurrence in mainstream tobacco smoke. Carcinogenesis 1991; 12: 257-261.
71. Jenkins RW et al. Neutron activation analysis in tobacco and cigarette smoke studies; The halogens. Beitr Tabakforsch Int 1982; 11: 195-202.
72. Kopplin A et al. Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke. Carcinogenesis 1995; 16: 2637-2641.
73. Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1994; 234: 16-33.
74. van Welie RTH, van Dijck RGJM, Vermeulen NPE. Mercapture acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol 1992; 22: 271-306.
75. van Doom R et al. Detection of human exposure to electrophilic compounds by assay of thioether detoxication products in urine. Ann Occup Hyg 1981; 24: 77-92.
76. Scherer G et al. Urinary mutagenicity and thioethers in nonsmokers: Role of environmental tobacco smoke (ETS) and diet. Mutat Res 1996; 368: 195-204.
77. Husgafvel-Pursiainen K, Sorsa M, Engström K, Einistö P. Passive smoking at work: biochemical and biological measures of exposure to environmental tobacco smoke, Int Arch Occup Environ Health 1985; 59: 337-345.
78. Kado NY et al. Use of a salmonella micro preincubation procedure for studying personal exposure to mutagens in environmental tobacco smoke: Pilot study of urine and airborne mutagenicity from passive smoking, in Sandhu SS, DeMarini DM, Mass MJ, Moore MM, Mumford JL (eds): Short-term bioassays in the analysis of complex environmental mixtures V. New York, London, Plenum Press, 1987: pp. 375-390.
79. Bartsch H et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1990; 82: 1826-1831.
80. Sasson IM et al. Mutagens in human urine: effects of cigarette smoking and diet. Mutat Res 1985; 158: 149-157.
81. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat Res 1983; 114: 59-89.
82. Sorsa M et al. Cytogenetic effects of tobacco smoke exposure among involuntary smokers. Mutat Res 1989; 222: 111-116.
83. Collman GW et al. Effects of α-naphthoflavone on levels of sister chromatid exchanges in lymphocytes from active and passive cigarette smokers: Dose-response relationships. Cancer Res 1986; 46: 6452-6455.
84. Gorgels WJMJ et al. Passive smoking and sister-chromatid exchanges in lymphocytes. Mutat Res 1992; 279: 233-238.
85. Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 1994; 24: 211-229.
86. Manchester DK, Jacoby EH. Sensitivity of human placental monooxygenase activity to maternal smoking. Clin Pharmacol Ther 1981; 30; 681-692.
87. Huel G et al. Aryl hydrocarbon hydroxylase activity in human placenta of passive smokers. Environ Res 1989; 50: 173-183.
88. Whyatt RM et al. CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarkers Prev 1995; 4: 147-153.
89. Remmer H. Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine. Arch Toxicol 1987; 61: 89-104.
90. Langness U. Hydroxyprolinausscheidung und Kollagenstoffwechsel. Dtsch Med Wochenschr 1970; 50: 2530-2535.
91. Kasuga H. An introduction to the study of smoking using urinary hydroxyproline, in Kasuga H (ed): Indoor Air Quality. Berlin, Springer-Verlag, 1990: pp. 37-52.
92. Adlkofer F, Scherer G, Heller W-D. Hydroxyproline excretion in urine of smokers and passive smokers. Prev Med 1984; 13: 670-679.
93. Verplanke AJW et al. Hydroxyproline excretion in schoolchildren and its relationship to measures of indoor air pollution. Int Arch Occup Environ Health 1987; 59: 221-231.
94. Adgate JL et al. Nitrogen dioxide exposure and urinary excretion of hydroxyproline and desmosine. Arch Environ Health 1992; 47: 376-384.
95. US Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. Rockville, Maryland, Public Health Service, 1983.
96. Glantz SA, Parmley WW. Passive smoking and heart disease. JAMA 1995; 273: 1047-1053.
97. Taylor AE, Johnson DC, Kazemi H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation 1992; 86: 699-702.
98. Smith CJ et al. Urinary thromboxane and prostacyclin are not altered in nonsmokers living with smokers. Blood 1997, submitted.
99. Sinzinger H, Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet 1982; 2: 392.
100. Burghuber OC et al. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest 1986; 89: 34-38.
101. Sinzinger H, Virgolini I: Besitzen Passivraucher ein erhöhtes Thromboserisiko? Wien Klin Wochenschr 1989; 101: 694-698.
102. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med 1989; 149: 386-389.
103. Howard G et al. Active and passive smoking are associated with increased carotid wall thickness. Arch Intern Med 1994; 154: 1277-1282.
104. Diez-Roux AV et al. The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med 1995; 24: 48-55.
105. Iso H et al. Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol 1996; 144: 1151-1154.
106. Kawachi I, Colditz GA. Invited commentary: Confounding, measurement error, and publication bias in studies of passive smoking. Am J Epidemiol 1996; 144: 909-915.
107. Feldman J et al. Passive smoking alters lipid profiles in adolescents. Pediatrics 1991; 88: 259-264.
108. Matanoski G, Kanchanaraksa S, Lantry D, Chang Y. Characteristics of nonsmoking women in NHANES I and NHANES I epidemiologic followup study with exposure to spouses who smoke. Am J Epidemiol 1995; 142: 149-157.
109. Svendsen KH, Kuller LJ, Martin MJ, Ockene JK. Effects of passive smoking in the multiple risk factor intervention trial. Am J Epidemiol 1987; 126: 783-795.
110. Szadkowski D, Harke HP, Angerer J. Kohlenmonoxydbelastung durch Passivrauchen in Büroräumen. Inn Med 1976; 3: 310-313.
111. Friedman GD, Petitti DB, Bawol RD. Prevalence and correlates of passive smoking. Am J Publ Health 1983; 73: 401-405.
112. Jarvis M et al. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Commun Health 1984; 38: 335-339.
113. Tunstall-Pedoe H, Woodward M, Brown CA. Tea drinking, passive smoking, smoking deception and serum cotinine in the Scottish Heart Health Study. J Clin Epidemiol 1991; 44: 1411-1414.
114. Scherer G, Conze C, Angerer J, Adlkofer F. Non-occupational exposure to benzene, in Mohr U (ed): Advances in Controlled Clinical Inhalation Studies. Berlin, Heidelberg, Springer-Verlag, 1993: pp. 387-392.
115. Wallace LA et al. Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 1987; 42: 272-279.
116. Buratti M et al. Evaluation of urinary t,t-muconic acid as a biomarker of benzene exposure related to ETS, in Maroni M (ed): healty buildings '95 an international conference on healthy buildings in mild climate. Milano, healthy buildings '95, 1995: vol 2, pp. 605-609.
117. Maclure M et al. Elevated blood levels of carcinogens in passive smokers. Am J Publ Health 1989; 79: 1381-1384.
118. Celermajer DS et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. New Engl J Med 1996; 334: 150-154.
119. Moskowitz WB et al. Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study. Circulation 1990; 81: 586-592.